A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns
Open Access
- 1 January 2014
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 55 (1), 146-154
- https://doi.org/10.1194/jlr.p043273
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Differential diagnosis in patients with suspected bile acid synthesis defectsWorld Journal of Gastroenterology, 2012
- Profiling sterols in cerebrotendinous xanthomatosis: Utility of Girard derivatization and high resolution exact mass LC–ESI-MSn analysisJournal of Chromatography B, 2011
- Successful heterozygous living donor liver transplantation for an oxysterol 7α-hydroxylase deficiency in a Japanese patientLiver Transplantation, 2011
- Four novel CYP27A1 mutations in seven Italian patients with CTXEuropean Journal of Neurology, 2010
- Measurement of serum 7α‐hydroxy‐4‐cholesten‐3‐one (or 7αC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography‐tandem mass spectrometryNeurogastroenterology & Motility, 2009
- Plasma Plant Sterol Levels Do Not Reflect Cholesterol Absorption in Children with Smith-Lemli-Opitz SyndromeThe Journal of Pediatrics, 2009
- Sequence Alterations within CYP7B1 Implicate Defective Cholesterol Homeostasis in Motor-Neuron DegenerationAmerican Journal of Human Genetics, 2008
- Novel LC–MS/MS method for assay of 7α-hydroxy-4-cholesten-3-one in human plasma: Evidence for a significant extrahepatic metabolismJournal of Chromatography B, 2007
- Fast atom bombardment mass spectrometry in the diagnosis of cerebrotendinous xanthomatosisScandinavian Journal of Clinical and Laboratory Investigation, 1985
- Long-Term Treatment of Cerebrotendinous Xanthomatosis with Chenodeoxycholic AcidNew England Journal of Medicine, 1984